Market Tracker

01/30 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

1.87
Data as of Jan 30
 -0.10 / -5.08%
Today’s Change
1.26
Today|||52-Week Range
7.58
+29.86%
Year-to-Date

Today’s Trading

Previous close1.97
Today’s open1.95
Day’s range1.81 - 1.97
Volume3,254,611
Average volume (3 months)2,762,082
Market cap$365.1M
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-5.01%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...-0.29-4.39%
FLXNFlexion Therapeutics...-1.07-4.94%
BSTCBiospecifics Technol...-1.61-3.93%
QLTIQLT Inc-0.03-0.69%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts